NAYA Biosciences Net Profit Margin 2010-2024 | IVF

NAYA Biosciences net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
NAYA Biosciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $0.01B $-0.01B -142.86%
2024-09-30 $0.01B $-0.01B -133.33%
2024-06-30 $0.01B $-0.01B -116.67%
2024-03-31 $0.00B $-0.01B -175.00%
2023-12-31 $0.00B $-0.01B -400.00%
2023-09-30 $0.00B $-0.01B -900.00%
2023-06-30 $0.00B $-0.01B 0.00%
2023-03-31 $0.00B $-0.01B 0.00%
2022-12-31 $0.00B $-0.01B 0.00%
2022-09-30 $0.00B $-0.01B -300.00%
2022-06-30 $0.00B $-0.01B -266.67%
2022-03-31 $0.00B $-0.01B -233.33%
2021-12-31 $0.00B $-0.01B -150.00%
2021-09-30 $0.00B $-0.01B -1000.00%
2021-06-30 $0.00B $-0.01B -1000.00%
2021-03-31 $0.00B $-0.01B -900.00%
2020-12-31 $0.00B $-0.01B 0.00%
2020-09-30 $0.00B $-0.01B 0.00%
2020-06-30 $0.00B $0.00B 0.00%
2020-03-31 $0.00B $0.00B -300.00%
2019-12-31 $0.00B $0.00B -200.00%
2019-09-30 $0.00B $0.00B -200.00%
2019-06-30 $0.00B $0.00B -100.00%
2019-03-31 $0.00B $0.00B 0.00%
2018-12-31 $0.00B $0.00B 0.00%
2018-09-30 $0.00B $0.00B 0.00%
2018-06-30 $0.00B $0.00B 0.00%
2018-03-31 $0.00B 0 0.00%
2017-12-31 $0.00B 0 0.00%
2017-09-30 $0.00B 0 0.00%
2017-06-30 $0.00B 0 0.00%
2017-03-31 $0.00B $0.00B 0.00%
2016-12-31 $0.00B $0.00B 0.00%
2016-06-30 $0.00B $0.00B 0.00%
2016-03-31 $0.00B $0.00B 0.00%
2015-09-30 $0.00B $0.00B 0.00%
2015-06-30 $0.00B $0.00B 0.00%
2015-03-31 $0.00B 0 0.00%
2011-12-31 $0.00B 0 0.00%
2011-09-30 $0.00B 0 0.00%
2011-03-31 $0.00B 0 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.001B $0.007B
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
Stock Name Country Market Cap PE Ratio
MYT Netherlands Parent B.V (LUXE) DE $0.643B 0.00
CAPITA (CTAYD) GB $0.274B 0.00
SAG Holdings (INEO) SG $0.013B 0.00
Aerovate Therapeutics (JBIO) US $0.010B 0.00